Efavirenz as a potential drug for the treatment of triple-negative breast cancers
Pey-Tsyr Chiou, S. Ohms, P. G. Board, Jane E. Dahlstrom, Danny Rangasamy, Marco G. Casarotto
Topics & Concepts
MedicineEfavirenzDrugOncologyTriple negativeInternal medicineTriple-negative breast cancerBreast cancerGynecologyPharmacologyCancerHuman immunodeficiency virus (HIV)Family medicineAntiretroviral therapyViral loadCancer, Lipids, and MetabolismViral-associated cancers and disordersT-cell and Retrovirus Studies